tis - ready for launch

I think we are in for a cracker 18 months for TIS. Allowing for some slippage in target dates, as is common for small companies like TIS, just have a look at all the upcoming catalysts for the share price:

Now to end July: Results from European/Australian trials for VitroGro. I'm expecting excellent results (compared with alternative treatments available) based on previous live skin work and a previous trial.

Now to Sep/Oct: Expected announcement of a partnership deal, including an up-front cash payment to TIS from partner, further milestone payments, around 10% royalties on all sales, plus manufacturing fees.

Now to Sep/Oct: Announcement of classification of VitroGro as a device by US FDA (Low risk as this classification has already been granted by Canada and Europe).

Jan12 to Jun12: Approval for sale of VitroGro in Europe + payment of milestone payment by partner.

Apr12 to Sep12: Sales launch in EU, >25% of world market ($30B by December 2014).

Jul12 to Dec12: Commencement of world-wide launch outside EU and US.

The really big catalyst after this is US approvals and sales which are planned to follow from around Jun 2013 to Mar 2014. By December 2014, VitroGro should be the best product for curing ulcers in a then US$30B world market (TIS Prospectus), growing at 25% a year (TIS Prospectus).

DYOR